778 related articles for article (PubMed ID: 36174227)
41. Development of new peptide vectors for the transport of therapeutic across the blood-brain barrier.
Gabathuler R
Ther Deliv; 2010 Oct; 1(4):571-86. PubMed ID: 22833968
[TBL] [Abstract][Full Text] [Related]
42. Recent progress of drug nanoformulations targeting to brain.
Khan AR; Yang X; Fu M; Zhai G
J Control Release; 2018 Dec; 291():37-64. PubMed ID: 30308256
[TBL] [Abstract][Full Text] [Related]
43. CNS drug delivery systems: novel approaches.
Pathan SA; Iqbal Z; Zaidi SM; Talegaonkar S; Vohra D; Jain GK; Azeem A; Jain N; Lalani JR; Khar RK; Ahmad FJ
Recent Pat Drug Deliv Formul; 2009 Jan; 3(1):71-89. PubMed ID: 19149731
[TBL] [Abstract][Full Text] [Related]
44. Targeted delivery of nano-therapeutics for major disorders of the central nervous system.
Gao H; Pang Z; Jiang X
Pharm Res; 2013 Oct; 30(10):2485-98. PubMed ID: 23797465
[TBL] [Abstract][Full Text] [Related]
45. Use of LDL receptor-targeting peptide vectors for
Molino Y; David M; Varini K; Jabès F; Gaudin N; Fortoul A; Bakloul K; Masse M; Bernard A; Drobecq L; Lécorché P; Temsamani J; Jacquot G; Khrestchatisky M
FASEB J; 2017 May; 31(5):1807-1827. PubMed ID: 28108572
[TBL] [Abstract][Full Text] [Related]
46. Peptides and Drug Delivery.
Ulapane KR; Kopec BM; Moral MEG; Siahaan TJ
Adv Exp Med Biol; 2017; 1030():167-184. PubMed ID: 29081054
[TBL] [Abstract][Full Text] [Related]
47. Drug delivery to the CNS and polymeric nanoparticulate carriers.
Costantino L
Future Med Chem; 2010 Nov; 2(11):1681-701. PubMed ID: 21428839
[TBL] [Abstract][Full Text] [Related]
48. Current approaches for drug delivery to central nervous system.
Hossain S; Akaike T; Chowdhury EH
Curr Drug Deliv; 2010 Dec; 7(5):389-97. PubMed ID: 20950269
[TBL] [Abstract][Full Text] [Related]
49. Challenges and new strategies for therapeutic peptide delivery to the CNS.
McGowan JW; Bidwell GL; Vig PJ
Ther Deliv; 2015 Jul; 6(7):841-53. PubMed ID: 26228775
[TBL] [Abstract][Full Text] [Related]
50. Potential approaches for drug delivery to the brain: past, present, and future.
Soni V; Jain A; Khare P; Gulbake A; Jain SK
Crit Rev Ther Drug Carrier Syst; 2010; 27(3):187-236. PubMed ID: 20540687
[TBL] [Abstract][Full Text] [Related]
51. Nanotechnology approaches to crossing the blood-brain barrier and drug delivery to the CNS.
Silva GA
BMC Neurosci; 2008 Dec; 9 Suppl 3(Suppl 3):S4. PubMed ID: 19091001
[TBL] [Abstract][Full Text] [Related]
52. Combination of cell-penetrating peptides with nanomaterials for the potential therapeutics of central nervous system disorders: a review.
Zhang Y; Guo P; Ma Z; Lu P; Kebebe D; Liu Z
J Nanobiotechnology; 2021 Aug; 19(1):255. PubMed ID: 34425832
[TBL] [Abstract][Full Text] [Related]
53. [Strategies for drug delivery to the brain across the blood-brain barrier].
Tsuji A
Nihon Rinsho; 1998 Mar; 56(3):613-8. PubMed ID: 9549345
[TBL] [Abstract][Full Text] [Related]
54. Jumping Hurdles: Peptides Able To Overcome Biological Barriers.
Sánchez-Navarro M; Teixidó M; Giralt E
Acc Chem Res; 2017 Aug; 50(8):1847-1854. PubMed ID: 28715199
[TBL] [Abstract][Full Text] [Related]
55. Recent advances in drug delivery and targeting to the brain.
Sethi B; Kumar V; Mahato K; Coulter DW; Mahato RI
J Control Release; 2022 Oct; 350():668-687. PubMed ID: 36057395
[TBL] [Abstract][Full Text] [Related]
56. Cell-Penetrating and Targeted Peptides Delivery Systems as Potential Pharmaceutical Carriers for Enhanced Delivery across the Blood-Brain Barrier (BBB).
Ghorai SM; Deep A; Magoo D; Gupta C; Gupta N
Pharmaceutics; 2023 Jul; 15(7):. PubMed ID: 37514185
[TBL] [Abstract][Full Text] [Related]
57. Nose-to-brain delivery of nanotherapeutics: Transport mechanisms and applications.
Xu K; Duan S; Wang W; Ouyang Q; Qin F; Guo P; Hou J; He Z; Wei W; Qin M
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2024; 16(2):e1956. PubMed ID: 38558503
[TBL] [Abstract][Full Text] [Related]
58. Application of the Phage Display Technology for the Development of Peptide- mediated Drug Delivery Systems through the Blood-Brain Barrier.
Suárez VM; Vispo NS; Ramos OS
Curr Pharm Biotechnol; 2021; 22(11):1394-1403. PubMed ID: 33397231
[TBL] [Abstract][Full Text] [Related]
59. In-vitro blood-brain barrier models for drug screening and permeation studies: an overview.
Bagchi S; Chhibber T; Lahooti B; Verma A; Borse V; Jayant RD
Drug Des Devel Ther; 2019; 13():3591-3605. PubMed ID: 31695329
[TBL] [Abstract][Full Text] [Related]
60. Crossing the Blood-Brain Barrier: Recent Advances in Drug Delivery to the Brain.
Patel MM; Patel BM
CNS Drugs; 2017 Feb; 31(2):109-133. PubMed ID: 28101766
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
